Literature DB >> 23962178

Cytomegalovirus contributes partly to uraemia-associated premature immunological ageing of the T cell compartment.

R W J Meijers1, N H R Litjens, E A de Wit, A W Langerak, A van der Spek, C C Baan, W Weimar, M G H Betjes.   

Abstract

Cytomegalovirus (CMV) infection has been implicated in accelerated T cell ageing. End-stage renal disease (ESRD) patients have a severely immunologically aged T cell compartment but also a high prevalence of CMV infection. We investigated whether CMV infection contributes to T cell ageing in ESRD patients. We determined the thymic output by the T cell receptor excision circle (TREC) content and percentage of CD31+ naïve T cells. The proliferative history of the T cell compartment by determination of the relative telomere length (RTL) and the T cell differentiation status was determined by immunophenotyping. It appeared that CMV infection did not affect thymic output but reduced RTL of CD8+ T cells in ESRD patients. Moreover, increased T cell differentiation was observed with higher percentages of CD57+ and CD28null CD4+ and CD8+ memory T cells. These CD28null T cells had significantly shorter telomeres compared to CD28+ T cells. Therefore we concluded that CMV infection does not affect the decreased thymic output but increases T cell differentiation as observed in ESRD-related premature T cell ageing.
© 2013 British Society for Immunology.

Entities:  

Keywords:  T lymphocytes; ageing; cytomegalovirus; end-stage renal disease; telomeres

Mesh:

Substances:

Year:  2013        PMID: 23962178      PMCID: PMC3826308          DOI: 10.1111/cei.12188

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  35 in total

Review 1.  Premature ageing of the immune system: the cause of AIDS?

Authors:  Victor Appay; Sarah L Rowland-Jones
Journal:  Trends Immunol       Date:  2002-12       Impact factor: 16.687

Review 2.  A killer on the road: circulating CD4(+)CD28null T cells as cardiovascular risk factor in ESRD patients.

Authors:  Michiel G H Betjes; Ruud W J Meijers; Lucia E A de Wit; Nicolle H R Litjens
Journal:  J Nephrol       Date:  2012 Mar-Apr       Impact factor: 3.902

Review 3.  HIV infection, inflammation, immunosenescence, and aging.

Authors:  Steven G Deeks
Journal:  Annu Rev Med       Date:  2011       Impact factor: 13.739

Review 4.  T cell exhaustion.

Authors:  E John Wherry
Journal:  Nat Immunol       Date:  2011-06       Impact factor: 25.606

5.  Mortality caused by sepsis in patients with end-stage renal disease compared with the general population.

Authors:  M J Sarnak; B L Jaber
Journal:  Kidney Int       Date:  2000-10       Impact factor: 10.612

6.  Premature aging of circulating T cells in patients with end-stage renal disease.

Authors:  Michiel G H Betjes; Anton W Langerak; Ashley van der Spek; Elly A de Wit; Nicolle H R Litjens
Journal:  Kidney Int       Date:  2011-04-27       Impact factor: 10.612

7.  Epstein-Barr virus but not cytomegalovirus is associated with reduced vaccine antibody responses in Gambian infants.

Authors:  Beth Holder; David J C Miles; Steve Kaye; Sarah Crozier; Nuredin Ibrahim Mohammed; Nancy O Duah; Elishia Roberts; Olubukola Ojuola; Melba S Palmero; Ebrima S Touray; Pauline Waight; Matthew Cotten; Sarah Rowland-Jones; Marianne van der Sande; Hilton Whittle
Journal:  PLoS One       Date:  2010-11-17       Impact factor: 3.240

8.  Cytomegalovirus-seropositivity has a profound influence on the magnitude of major lymphoid subsets within healthy individuals.

Authors:  S Chidrawar; N Khan; W Wei; A McLarnon; N Smith; L Nayak; P Moss
Journal:  Clin Exp Immunol       Date:  2009-03       Impact factor: 4.330

Review 9.  Immune cell dysfunction and inflammation in end-stage renal disease.

Authors:  Michiel G H Betjes
Journal:  Nat Rev Nephrol       Date:  2013-03-19       Impact factor: 28.314

10.  The pattern of excess cancer in dialysis and transplantation.

Authors:  John H Stewart; Claire M Vajdic; Marina T van Leeuwen; Janaki Amin; Angela C Webster; Jeremy R Chapman; Stephen P McDonald; Andrew E Grulich; Margaret R E McCredie
Journal:  Nephrol Dial Transplant       Date:  2009-07-08       Impact factor: 5.992

View more
  17 in total

1.  Mesenchymal stem cells control alloreactive CD8(+) CD28(-) T cells.

Authors:  A U Engela; C C Baan; N H R Litjens; M Franquesa; M G H Betjes; W Weimar; M J Hoogduijn
Journal:  Clin Exp Immunol       Date:  2013-12       Impact factor: 4.330

2.  HIV-1 Vpr disrupts mitochondria axonal transport and accelerates neuronal aging.

Authors:  Ying Wang; Maryline Santerre; Italo Tempera; Kayla Martin; Ruma Mukerjee; Bassel E Sawaya
Journal:  Neuropharmacology       Date:  2017-02-14       Impact factor: 5.250

Review 3.  Chronic kidney disease and premature ageing of the adaptive immune response.

Authors:  Michiel G H Betjes; Nicolle H R Litjens
Journal:  Curr Urol Rep       Date:  2015-01       Impact factor: 3.092

4.  Co-inhibitory profile and cytotoxicity of CD57+ PD-1- T cells in end-stage renal disease patients.

Authors:  R Kraaijeveld; G N de Graav; M Dieterich; N H R Litjens; D A Hesselink; C C Baan
Journal:  Clin Exp Immunol       Date:  2017-11-09       Impact factor: 4.330

Review 5.  T-cell ageing in end-stage renal disease patients: Assessment and clinical relevance.

Authors:  Ruud Wj Meijers; Michiel Gh Betjes; Carla C Baan; Nicolle Hr Litjens
Journal:  World J Nephrol       Date:  2014-11-06

Review 6.  T-cell aging in end-stage renal disease: an evolving story with CMV.

Authors:  TienYu Owen Yang; Yi-Fang Chuang; Yen-Ling Chiu
Journal:  Med Microbiol Immunol       Date:  2019-03-21       Impact factor: 3.402

Review 7.  CD28 negative T cells: is their loss our gain?

Authors:  D Mou; J Espinosa; D J Lo; A D Kirk
Journal:  Am J Transplant       Date:  2014-10-16       Impact factor: 8.086

8.  Latency for cytomegalovirus impacts T cell ageing significantly in elderly end-stage renal disease patients.

Authors:  L Huang; A W Langerak; C C Baan; N H R Litjens; M G H Betjes
Journal:  Clin Exp Immunol       Date:  2016-08-19       Impact factor: 4.330

9.  Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials.

Authors:  Birgit Sawitzki; Paul N Harden; Petra Reinke; Aurélie Moreau; James A Hutchinson; David S Game; Qizhi Tang; Eva C Guinan; Manuela Battaglia; William J Burlingham; Ian S D Roberts; Mathias Streitz; Régis Josien; Carsten A Böger; Cristiano Scottà; James F Markmann; Joanna L Hester; Karsten Juerchott; Cecile Braudeau; Ben James; Laura Contreras-Ruiz; Jeroen B van der Net; Tobias Bergler; Rossana Caldara; William Petchey; Matthias Edinger; Nathalie Dupas; Michael Kapinsky; Ingrid Mutzbauer; Natalie M Otto; Robert Öllinger; Maria P Hernandez-Fuentes; Fadi Issa; Norbert Ahrens; Christoph Meyenberg; Sandra Karitzky; Ulrich Kunzendorf; Stuart J Knechtle; Josep Grinyó; Peter J Morris; Leslie Brent; Andrew Bushell; Laurence A Turka; Jeffrey A Bluestone; Robert I Lechler; Hans J Schlitt; Maria C Cuturi; Stephan Schlickeiser; Peter J Friend; Tewfik Miloud; Alexander Scheffold; Antonio Secchi; Kerry Crisalli; Sang-Mo Kang; Rachel Hilton; Bernhard Banas; Gilles Blancho; Hans-Dieter Volk; Giovanna Lombardi; Kathryn J Wood; Edward K Geissler
Journal:  Lancet       Date:  2020-05-23       Impact factor: 202.731

10.  End stage renal disease patients have a skewed T cell receptor Vβ repertoire.

Authors:  Ling Huang; Anton W Langerak; Ingrid L M Wolvers-Tettero; Ruud W J Meijers; Carla C Baan; Nicolle H R Litjens; Michiel G H Betjes
Journal:  Immun Ageing       Date:  2015-12-14       Impact factor: 6.400

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.